Perceptive Advisors
Venture Capital
Active
New York, United States
276
96M
203
11.04
59
0.26
109
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main department of described VC is located in the New York.
We also calculated 3 valuable employees in our database.
The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2019. This Perceptive Advisors works on 28 percentage points more the average amount of lead investments comparing to the other organizations. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The typical startup value when the investment from Perceptive Advisors is 100-500 millions dollars. The common things for fund are deals in the range of 50 - 100 millions dollars. The increased amount of exits for fund were in 2018.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Allogene Therapeutics, BridgeBio, Alector. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Genetics, Biopharma.
The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the Perceptive Advisors, startups are often financed by Third Rock Ventures, F-Prime Capital, Morgenthaler Ventures. The meaningful sponsors for the fund in investment in the same round are ArrowMark Partners, RTW Investments LLC, Viking Global Investors. In the next rounds fund is usually obtained by OrbiMed, Pontifax, Warburg Pincus.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
- Check size
- 15M — 200M
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 276
- Lead investments
- 59
- Exits
- 109
- Rounds per year
- 11.04
- Follow on index
- 0.26
- Investments by industry
- Biotechnology (221)
- Health Care (158)
- Medical (100)
- Therapeutics (90)
- Pharmaceutical (72) Show 57 more
- Investments by region
-
- United States (235)
- United Kingdom (12)
- China (3)
- Germany (6)
- Canada (7) Show 7 more
- Peak activity year
- 2021
- Number of Unicorns
- 5
- Number of Decacorns
- 5
- Number of Minotaurs
- 14
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 75M
- Group Appearance index
- 0.87
- Avg. company exit year
- 10
- Avg. multiplicator
- 0.99
- Strategy success index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Capstan Therapeutics | 20 Mar 2024 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 175M | United States, California, San Diego |
Talkiatry | 18 Jun 2024 | Fitness, Health Care, Medical | Late Stage Venture | 130M | United States, New York, New York |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.